SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-080874
Filing Date
2024-03-28
Accepted
2024-03-28 17:20:12
Documents
19
Period of Report
2024-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d807060d8k.htm   iXBRL 8-K 34257
2 EX-1.1 d807060dex11.htm EX-1.1 171167
3 EX-4.1 d807060dex41.htm EX-4.1 68102
4 EX-5.1 d807060dex51.htm EX-5.1 18036
5 EX-99.1 d807060dex991.htm EX-99.1 10718
9 GRAPHIC g807060dsp53.jpg GRAPHIC 3179
10 GRAPHIC g807060dsp53a.jpg GRAPHIC 2957
  Complete submission text file 0001193125-24-080874.txt   517613

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stok-20240327.xsd EX-101.SCH 2881
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20240327_lab.xml EX-101.LAB 17979
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20240327_pre.xml EX-101.PRE 11279
22 EXTRACTED XBRL INSTANCE DOCUMENT d807060d8k_htm.xml XML 3627
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 24800474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)